Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery

Experimental and Therapeutic Medicine
Y I HanZhidong Liu

Abstract

Chest wall tuberculosis (TB) is an endemic disease with a large number of variants. The condition affects numerous parts of the body and can penetrate the skin to form chronic open ulcers. Current treatment methods include oral anti-TB drugs and surgery. However, conventional drug treatments are not effective due to the difficulty in achieving an effective local concentration, and certain patients are unable to tolerate surgery. The recurrence rate for chest wall TB is high following surgery, and may result in the prolonged healing of wounds in certain patients, as well as chronic sinusitis and fistula formation. To identify a safe, simple, less invasive and more clinically effective treatment method, the present study investigated transdermal ultrasound-mediated anti-TB drug delivery. A total of 186 patients were selected and randomly divided into transdermal ultrasound, surgery and oral anti-TB drug only groups. Rifampicin was the drug delivered by transdermal ultrasound. The cure and efficiency rates were shown to be 87.10 and 93.55%, respectively, in the ultrasound treatment group. No statistically significant difference was observed in the cure rates between the transdermal ultrasound and surgery groups; however, a statist...Continue Reading

References

Jun 1, 1995·Journal of Pharmaceutical Sciences·S MitragotriR Langer
Oct 16, 2002·Annals of the Rheumatic Diseases·R Kurth, W H Haas
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Jacques Grosset
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·Rajesh GuptaMario C Raviglione
Sep 17, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ilana LavonJoseph Kost
Apr 25, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Vaibhav DubeyN K Jain
Aug 3, 2007·Interactive Cardiovascular and Thoracic Surgery·Akin KuzucuHakan Günen
Jan 27, 2009·Progress in Histochemistry and Cytochemistry·Richard H W FunkNurdan Ozkucur
Mar 21, 2009·Journal of Cutaneous Medicine and Surgery·Alper GözübüyükOnur Genç
May 16, 2009·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Leonardo D D SimonettiRenata F V Lopez
Jul 1, 2008·Lung India : Official Organ of Indian Chest Society·G S Gaude, Ak Reyas
Feb 25, 2010·Annals of Plastic Surgery·So-Young LimKap-Sung Oh
Apr 2, 2011·Mayo Clinic Proceedings·Irene G Sia, Mark L Wieland
Dec 21, 2011·Interactive Cardiovascular and Thoracic Surgery·Satona TanakaAkihiko Ikeda
Jan 14, 2012·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Bo DengYong-Gang Liang
Mar 1, 2012·The Annals of Thoracic Surgery·Ni ZhangWei Sun
Jun 19, 2012·The Korean Journal of Thoracic and Cardiovascular Surgery·Dong-Yoon KeumChang-Kwon Park
Sep 4, 2012·Journal of Controlled Release : Official Journal of the Controlled Release Society·Carl M SchoellhammerDaniel Blankschtein
Jun 15, 2013·Anesthesia Progress·Joseph L PackerMahmoud Torabinejad

❮ Previous
Next ❯

Citations

Feb 13, 2019·Current Pharmaceutical Design·Saloni DaftardarAmit K Tiwari

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

IEEE Engineering in Medicine and Biology Magazine : the Quarterly Magazine of the Engineering in Medicine & Biology Society
Eric C Pua, Pei Zhong
© 2021 Meta ULC. All rights reserved